Centre Testing International Group (300012) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
20 Apr, 2026Executive summary
Revenue for Q1 2026 reached ¥1,494.85 million, up 16.17% year-over-year.
Net profit attributable to shareholders was ¥178.32 million, a 30.93% increase year-over-year.
Operating cash flow turned positive at ¥1.66 million, compared to a negative ¥89.94 million in Q1 2025.
EBITDA rose 20.77% year-over-year to ¥338.67 million.
Financial highlights
Gross margin improved as revenue growth outpaced cost increases.
Net profit margin increased due to higher revenue and improved cost control.
Basic and diluted EPS both at ¥0.1066, up from ¥0.0814 year-over-year.
Return on equity (ROE) rose to 2.30%, up 0.35 percentage points year-over-year.
Total assets at quarter-end were ¥10,354.06 million, slightly down 0.24% from year-end 2025.
Outlook and guidance
Management expects continued growth driven by expanded service offerings and recent acquisitions.
Focus remains on operational efficiency and cash flow improvement.
Latest events from Centre Testing International Group
- Revenue and profit rose over 10% with robust cash flow and global expansion.300012
Q4 202531 Mar 2026 - 2023 revenue up 9.24% and net profit up 0.83%, driven by strategic growth and digitalization.300012
Q4 202313 Mar 2026 - 2024 saw 8.55% revenue growth, margin expansion, and robust R&D amid strategic M&A and digital upgrades.300012
Q4 202413 Mar 2026 - H1 2025 revenue and profit rose over 6%, driven by digitalization and global expansion.300012
Q2 202516 Dec 2025 - Q3 2025 saw double-digit net profit growth and strong cash flow, driven by robust operations.300012
Q3 202516 Dec 2025